+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Implantable Drug Delivery Device Market (2021-2026) by Product, Type, Technology, Application, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • ID: 5410423
  • Report
  • June 2021
  • Region: Global
  • 193 Pages
  • Infogence Global Research
UP TO OFF
until Jan 31st 2022

FEATURED COMPANIES

  • 3M Company
  • Alimera Sciences
  • Delpor Inc.
  • Flowonix
  • Medtronic Plc.
  • Siemens Healthineers
The Global Implantable Drug Delivery Device Market is estimated to be USD 18.35 Bn in 2021 and is expected to reach USD 28.82 Bn by 2026, growing at a CAGR of 9.45%.



Market Dynamics

The growth of the implantable drug-device market is driven by factors such as the growing prevalence of chronic disease, the rising awareness amongst people regarding implantable drug delivery devices, increasing demand for contraceptives, and intervention by government and health organizations to ensure high patient safety standards. In addition, the rising awareness about the availability of high quality and safer products, recent advancements in medication administration techniques, and rapid increasing research and development for new product launch and elimination of existing problems are expected to fuel growth potential over the coming years.

However, the chances of implanted device failures, strict government regulations and policies, and the high cost of devices are expected to restrain the market growth in the forecasted period.

Market Segmentation

The Global Implantable Drug Delivery Device Market is segmented further based on Product, Type, Technology, Application, End-User, and Geography.

By Product, the market is classified into Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bioabsorbable Stents, Intraocular Implants, Infusion Pumps, and Others. Amongst all, the Drug-Eluting Stents segment is estimated to hold the highest market share during the forecast period.

By Type, the market is classified as Bio-Degradable And Non-Biodegradable. Amongst the two, the Non-Biodegradable segment is estimated to hold the highest market share during the forecast period.

By Technology, the market is classified as Diffusion, Osmotic, and Magnetic. Amongst all, the Diffusion segment is estimated to hold the highest market share during the forecast period.

By Application, the market is classified as Ophthalmology, Cardiology, Obstetrics And Gynecology, Diabetes, Oncology, Auto-Immune Diseases, and Others. Amongst all, the Cardiovascular segment is estimated to hold the highest market share during the forecast period.

By End-User, the market is classified as Hospitals, Ambulatory Surgery Centers, and Others. Amongst all, the Hospitals segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. FDA accepts application for Roche’s Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD). If approved, PDS would be the first and only eye implant with continuous drug delivery that offers people living with nAMD an alternative to frequent eye injections - 24th June 2021.
2. Siemens Healthineers acquired Varian, strengthening its position as a holistic partner in healthcare -15th April 2021

Company Profiles

Some of the companies covered in this report are Allergan, Bayer AG, Medtronic, Abbott, Varian Medical Systems Inc., etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Implantable Drug Delivery Device Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Alimera Sciences
  • Delpor Inc.
  • Flowonix
  • Medtronic Plc.
  • Siemens Healthineers
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook

4 Market Influencers
4.1 Drivers
4.1.1 Growing Prevalence of Chronic Diseases
4.1.2 Increasing Demand for Minimally Invasive Drug Delivery Devices
4.2 Restraints
4.2.1 Strict Government Regulations
4.2.2 High Device Cost
4.3 Opportunities
4.3.1 Collaboration Activities Among Key Players
4.4 Challenges
4.4.1 Product Recall
4.5 Trends

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis

6 Global Implantable Drug Delivery Device Market, By Product
6.1 Introduction
6.2 Contraceptive Implants
6.3 Spinal Implants
6.4 Brachytherapy Seeds
6.5 Drug-Eluting Stents
6.6 Bioabsorbable Stents
6.7 Intraocular Implants
6.8 Infusion Pumps
6.9 Others

7 Global Implantable Drug Delivery Device Market, By Type
7.1 Introduction
7.2 Bio-Degradable
7.3 Non-Biodegradable

8 Global Implantable Drug Delivery Device Market, By Technology
8.1 Introduction
8.2 Diffusion
8.3 Osmotic
8.4 Magnetic

9 Global Implantable Drug Delivery Device Market, By Application
9.1 Introduction
9.2 Ophthalmology
9.3 Cardiology
9.4 Obstetrics And Gynecology
9.5 Diabetes
9.6 Oncology
9.7 Auto-Immune Diseases
9.8 Others

10 Others Global Implantable Drug Delivery Device Market, By End User
10.1 Introduction
10.2 Hospitals
10.3 Ambulatory Surgery Centres
10.4 Others

11 Global Implantable Drug Delivery Device Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 South America
11.3.1 Brazil
11.3.2 Argentina
11.3.3 Chile
11.3.4 Colombia
11.4 Europe
11.4.1 UK
11.4.2 France
11.4.3 Germany
11.4.4 Italy
11.4.5 Spain
11.4.6 Netherlands
11.4.7 Sweden
11.4.8 Russia
11.4.9 Rest of Europe
11.5 Asia-Pacific
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Indonesia
11.5.5 Malaysia
11.5.6 South Korea
11.5.7 Australia
11.5.8 Sri Lanka
11.5.9 Thailand
11.5.10 Rest of APAC
11.6 Middle-East and Africa
11.6.1 Qatar
11.6.2 Saudi Arabia
11.6.3 South Africa
11.6.4 United Arab Emirates

12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements

13 Company Profiles
13.1 Abbott Laboratories
13.2 AbbVie Inc
13.3 Allergan Inc
13.4 Alcon Inc.
13.5 Bayer AG
13.6 Bausch and Lomb Incorporated
13.7 Biotronik, Inc.
13.8 Boston Scientific Corporation
13.9 DSM Biomedical
13.10 Delpor Inc.
13.11 Medtronic Plc.
13.12 Merck & co., Inc.
13.13 Freudenberg Medical, LLC
13.14 Flowonix
13.15 Nucletron
13.16 Siemens Healthineers
13.17 Theradaptive, Inc.
13.18 Intersect ENT
13.19 Nanomedical Systems, Inc.
13.20 Intarcia Therapeutics
13.21 Teleflex Incorporated
13.22 Terumo Corporation
13.23 Alimera Sciences
13.24 Eyepoint Pharmaceuticals
13.25 Delpor Inc.
13.26 3M Company

14 Appendix
14.1 Questionnaire
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • AbbVie Inc
  • Allergan Inc
  • Alcon Inc.
  • Bayer AG
  • Bausch and Lomb Incorporated
  • Biotronik, Inc.
  • Boston Scientific Corporation
  • DSM Biomedical
  • Delpor Inc.
  • Medtronic Plc.
  • Merck & co., Inc.
  • Freudenberg Medical, LLC
  • Flowonix
  • Nucletron
  • Siemens Healthineers
  • Theradaptive, Inc.
  • Intersect ENT
  • Nanomedical Systems, Inc.
  • Intarcia Therapeutics
  • Teleflex Incorporated
  • Terumo Corporation
  • Alimera Sciences
  • Eyepoint Pharmaceuticals
  • Delpor Inc.
  • 3M Company
Note: Product cover images may vary from those shown

Loading
LOADING...